IndraLab

Statements


SiRNA treatment inhibits KCNA3. 1 / 1
| 1

eidos
"Our data are in line with results from Cidad et al ., who demonstrated an inhibition of femoral artery SMC proliferation when Kv1.3 was blocked pharmacologically with PAP-1 or with Margatoxin or when Kv1.3 was knocked down by siRNA treatment [ 22 ] ."